Clinical Trials Browser

OTHER × Endometrial Neoplasms × Hysterectomy × Clear all

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

NCT06800677 2025-01-30

BioMEC

Active not recruiting

200 enrolled

Gynecologic

Endometrial Neoplasms

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase EARLY_PHASE1 Terminated

3 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT04120649 2022-08-25

Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma

Completed

50 enrolled

Gynecologic

Endometrial Neoplasms

NCT05261165 2022-03-02

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

Completed

170 enrolled

Gynecologic

Endometrial Neoplasms

NCT00610740 2017-12-28

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Phase 2 Completed

18 enrolled 8 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Clinical Trials

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

BioMEC

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer